Gastrointestinal symptoms in the course
of COVID-19

Gastrointestinal symptoms in the course of COVID-19

COVID-19 is an infectious disease caused by novel coronavirus SARS-CoV-2, a betacoronavirus comprised of single-stranded ribonucleic acid (RNA), the first time reported in December 2019 as pneumonia with unknown etiology in Wuhan City in China. It is a very important current problem for public healt...

Full description

Bibliographic Details
Main Authors:	Grzegorz K. Jakubiak, Józefina Ochab-Jakubiak, Grzegorz Cieślar, Agata Stanek
Format:	Article
Language:	English
Published:	Index Copernicus International S.A. 2020-11-01
Series:	Postępy Higieny i Medycyny Doświadczalnej
Subjects:	COVID-19 diarrhoea abdominal pain liver injury angiotensin-converting enzyme 2
Online Access:	http://phmd.pl/gicid/01.3001.0014.5459

Similar Items

Angiotensin-Converting Enzyme Inhibitor-Induced Gastrointestinal Angioedema: The First Danish Case Report
by: Marijana Rincic Antulov, et al.
Published: (2018-09-01)

Angiotensin II and COVID-19. Secrets of interactions
by: A. O. Konradi, et al.
Published: (2020-05-01)

Abdominal Pain: A Real Challenge in Novel COVID-19 Infection
by: Erika Poggiali, et al.
Published: (2020-03-01)

Lisinopril-Induced Liver Injury: An Unusual Presentation and Literature Review
by: Ammar Al-Rifaie, et al.
Published: (2020-04-01)

Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19
by: Naci Şenkal, et al.
Published: (2020-07-01)

Serum angiotensin converting enzyme in pemphigus vulgaris
by: Reza M Robati, et al.
Published: (2014-01-01)

Debatable points of using angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in patients with COVID-19
by: O. M. Drapkina, et al.
Published: (2020-07-01)

A continuous fluorescent assay for the determination of plasma and tissue angiotensin I-converting enzyme activity
by: M.F. Alves, et al.
Published: (2005-06-01)

Angiotensin-converting Enzyme Inhibitors: Can it be a Potential Treatment of Infantile Hemangioma
by: Archika Gupta, et al.
Published: (2021-01-01)

Treatment of Patients with COVID-19 and Concomitant Cardiovascular Diseases: Do not Forget About the Principles of Evidence-based Medicine
by: S. Yu. Martsevich
Published: (2020-05-01)

Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
by: Si-Hyuck Kang, et al.
Published: (2021-06-01)

The Role of Glutathione in Protecting against the Severe Inflammatory Response Triggered by COVID-19
by: Francesca Silvagno, et al.
Published: (2020-07-01)

From gene to protein - experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension
by: Sheila K Patel, et al.
Published: (2014-06-01)

Angiotensin-Converting Enzymes Play a Dominant Role in Fertility
by: Fan Jin, et al.
Published: (2013-10-01)

The Angiotensin Converting Enzyme Deletion/Deletion Genotype Is a Risk Factor for Severe COVID-19: Implication and Utility for Patients Admitted to Emergency Department
by: Anna Annunziata, et al.
Published: (2021-08-01)

Cognitive impact of COVID-19: looking beyond the short term
by: Scott Miners, et al.
Published: (2020-12-01)

No harm from angiotensin-converting enzyme inhibitors or angiotensin receptor inhibitors in patients with COVID-19. Results of a prospective study on a hospital-based cohort
by: Gian Paolo Anzola, et al.
Published: (2020-09-01)

COVID-19: a hypothesis regarding the ventilation-perfusion mismatch
by: Mario G. Santamarina, et al.
Published: (2020-07-01)

Is diet partly responsible for differences in COVID-19 death rates between and within countries?
by: Jean Bousquet, et al.
Published: (2020-05-01)

Utility of angiotensin-converting enzyme activity in aqueous humor in the diagnosis of ocular sarcoidosis
by: Violeta Mihailovic-Vucinic, et al.
Published: (2017-01-01)

Human testis angiotensin-converting enzyme: Crystal structure of a glycosylation mutant and investigation of a putative hinge-mechanism by normal mode analysis.
by: Watermeyer, Jean Margaret
Published: (2004)

Human testis angiotensin-converting enzyme: Crystal structure of a glycosylation mutant and investigation of a putative hinge-mechanism by normal mode analysis.
by: Watermeyer, Jean Margaret
Published: (2004)

Human testis angiotensin-converting enzyme: crystal structure of a glycosylation mutant and investigation of a putative hinge-mechanism by normal mode analysis
by: Watermeyer, Jean Margaret
Published: (2013)

The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19
by: Philip Braude, et al.
Published: (2020-12-01)

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with COVID-19: General Considerations and Clinical Implications
by: Neiberg de Alcantara Lima, et al.
Published: (2020-06-01)

Relating angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers with incidence or mortality of COVID‐19
by: Martin C.S. Wong, et al.
Published: (2020-10-01)

Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19
by: Wentao Ni, et al.
Published: (2020-07-01)

Gastrointestinal Manifestations of COVID- 19
by: Mitra Ahadi, et al.
Published: (2020-07-01)

Gastrointestinal Manifestations of COVID- 19
by: Mitra Ahadi, et al.
Published: (2020-09-01)

Gastrointestinal Symptoms in Patients with COVID-19 and Usefulness of Stool Test
by: Sung Hoon Jung, et al.
Published: (2020-06-01)

2019 novel-coronavirus: Cardiovascular insights about risk factors, myocardial injury, therapy and clinical implications
by: Luigi Cappannoli, et al.
Published: (2020-12-01)

Rat angiotensin-converting enzyme : tissue specific expression during pharmacological inhibition
by: Brice, Edmund Andrew William
Published: (2018)

Gastric Duplication Cyst in a man Presenting with Elevated Liver Enzymes and Icterus
by: Seyed Ali Malekhosseini, et al.
Published: (2014-03-01)

Associations Between the Use of Renin–Angiotensin System Inhibitors and the Risks of Severe COVID-19 and Mortality in COVID-19 Patients With Hypertension: A Meta-Analysis of Observational Studies
by: Xiao-Ce Dai, et al.
Published: (2021-04-01)

Coronavirus Disease 2019 (COVID-19) in Children: Prevalence, Diagnosis, Clinical Symptoms, and Treatment
by: Zare-Zardini H, et al.
Published: (2020-07-01)

Angiotensin II Receptor Blockers but Not Angiotensin-Converting Enzyme Inhibitors Are Associated With a Reduced Risk of Acute Kidney Injury After Major Surgery
by: Shao-Yu Yang, et al.
Published: (2021-04-01)

COVID-19 morbidity and mortality associated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers use among 14,129 patients with hypertension from a US integrated healthcare system
by: Jaejin An, et al.
Published: (2021-06-01)

Association between COVID-19 and cardiovascular disease
by: Kamna Srivastava, Ph.D
Published: (2020-08-01)

RENIN-ANGIOTENSIN SYSTEM IN REGULATION OF HEMATOPOIESIS
by: M. L. Kanaeva, et al.
Published: (2018-02-01)

Pulmonary midkine inhibition ameliorates sepsis induced lung injury
by: Jing-Yuan Xu, et al.
Published: (2021-02-01)

Cannot write session to /tmp/vufind_sessions/sess_035b3oilpgtcrr3rf1cs6i8dms